D'Orazio & Associates, Inc.
Source: SEC Form 13F · as of Mar 2026D'Orazio & Associates, Inc. holds 21 biotech & pharma companies tracked by BioSniper, totaling $28.1M in value as of Mar 2026 (SEC Form 13F).
Companies held
21
Total value held
$28.1M
| Company | Shares | Value |
|---|---|---|
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 48,315 | $13.1M |
| JNJJOHNSON & JOHNSON | 9,900 | $2.4M |
| LLYELI LILLY & Co | 2,220 | $2.0M |
| PMPhilip Morris International Inc | 9,025 | $1.5M |
| ABBVAbbVie Inc. | 5,483 | $1.2M |
| AMGNAMGEN INC | 3,141 | $1.1M |
| GILDGILEAD SCIENCES, INC. | 7,160 | $998K |
| MCKMcKesson Corporation | 952 | $824K |
| PFEPFIZER INC | 27,146 | $762K |
| CAHCardinal Health Inc. | 3,075 | $650K |
| NVSNovartis AG | 4,187 | $640K |
| MRKMerck & Co., Inc. | 4,245 | $511K |
| ABTABBOTT LABORATORIES | 4,545 | $467K |
| BMYBRISTOL MYERS SQUIBB CO | 6,768 | $410K |
| BIIBBIOGEN INC. | 1,777 | $326K |
| PBYIPUMA BIOTECHNOLOGY, INC. | 49,915 | $319K |
| CORCencora Inc. | 724 | $227K |
| GMOptec International, Inc. | 2,995 | $223K |
| FMSFresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an Ordinary Share) | 8,905 | $201K |
| INNVINNOVUS PHARMACEUTICALS, INC. | 18,206 | $146K |
| NGENNERVGEN PHARMA CORP. | 10,000 | $38K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.